Chien-Yuan Eddy Lin1,2, Ai-Chi Chen1, Liang-Yu Shyu3, Yen-Chien Wu4, David Yen-Ting Chen4, Ying-Chi Tseng4, and Chi-Jen Chen4
1GE Healthcare, Taipei, Taiwan, 2GE Healthcare MR Research China, Beijing, People's Republic of China, 3Biomedical Engineering Department, Chung Yuan Christian University, Chungli, Taiwan, 4Department of Radiology, Taipei Medical University - Shuang Ho Hospital, New Taipei City, Taiwan
Synopsis
Accurate tracking of plaque composition would be very useful clinically to determine the status of atherosclerosis and to understand the potential risk under myocardial infraction, stroke, and peripheral vascular disease. We developed a semi-automatic software to evaluate the carotid plaque types using four contrast-weighted MRI (pre- and post-contrast T1-weighted, time-of-flight, T2-weighted). Working with the proposed software with the minimal operator input reduces the process time of plaque component identification and minimizes the possibility of random and systematic errors. As a result, proposed software is capable of assisting the radiologist/clinician in imaging interpretation and decision-making in managing carotid artery atherosclerosis.
Purpose
Atherosclerosis and its thrombotic complications are the leading cause
of death and disability in developed countries1. The resultant plaque may grow to obstruct the lumen or to disseminate material into the
blood stream and may cause myocardial infarction,
stroke, and peripheral vascular disease2. Accurate tracking of plaque
composition in vivo would be very useful clinically to determine the status of atherosclerosis.
Multicontrast MRI has been proven to be capable of detecting plaque morphology
such as plaque size/thickness and plaque tissue composition (lipid/necrotic cores, dense and loose fibrous matrix, hemorrhage and
calcifications)3. However, the lack of a harmonized processing pipeline
contributing to the quantitative analysis of plaque components with the less inter-operator
bias to minimize the possibility of random and systematic errors. In this work,
we described a semi-automatic software for analyzing the plaque morphology that
can automatically classify different carotid atherosclerotic lesion types once
operator determined the location of vessel walls from multicontrast MRI.Methods
Sixteen atherosclerosis patients were imaged in a 3T clinical scanner
(Discovery MR750, GE Healthcare, Milwaukee, USA) using an 8-channel brain coil
as the signal detection and whole body coil for RF transmission. A multicontrast protocol was applied for visualizing
carotid arteries at matched slice coverage and resolution (FOV=16 cm, thickness=3
mm, 256x256 matrix): time of flight (TOF), Pre-and post-contrast T1-weighted
(T1W and T1W+C, respectively) imaging, T2-weighted
(T2W) imaging. Fat suppression function was enabled at T1W and T2W
images for reducing signal from subcutaneous fatty tissues. Other parameters
for the imaging sequences were as follows: (1) 2D fast spin-echo sequence with
the preparation of double-inversion recovery for T1W and T1W+C (TR/TE=1 R-R/6
ms), for (2) T2W (TR/TE=2 R-R/48 ms); (3) 3D TOF SPGR sequence was used for detecting
flow-related enhancement (TR/TE=21/2.2ms, FA=20). Proposed analysis
software was developed in C++ environment. Plaque composition can be
automatically classified to four categories (lipid, calcification, fibrosis,
and hemorrhage) in accordance with the multiple image contrast and the change
of signal intensity as table 1 shown3, once the operator contours
the vessel lumen and outer wall boundaries. Fibrous tissue can be distinguished
from other three components according to the enhanced ratio of T1W+C, while
calcification tissue was isolated due to its low signal at all MR imaging. Hemorrhage
and lipid tissue can be identified from each other according to their different
TOF signal level (hyperintense and isointense, respectively). The accuracy in
the classification of plaque type by developed program showed an excellent
agreement with a experienced radiologist. As our testing, using developed
program for analyzing the plaque morphology with minimal operator input, more
than 34% process time was saved.Results and Discussions
Three of 16 cases were recruited for
demonstrating the identifications of plaque components using proposed process
software (Figure 1). Vessel wall and lumen were contoured by operator according
to multicontrast MRI and labeled as blue and red color, respectively. Several
information was displayed at resultant page (Figure 1b) once executing the
process. Firstly, the histogram analysis of the vessel wall thickness in the 16
radial directions was plotted. Secondly, the area of vessel wall and lumen as well
as four plaque components were exhibited. Lipid was identified as main
component and labeled as yellow color in Case A with the area of 34.77 mm2
(blue, green, and pink color for calcification, fibrosis, and hemorrhage,
respectively), because the ratio of T1W+C SSR (1.2) and T1W SSR (1.8) is
smaller than 1 (denote as “-“ at T1W+C) and TOF signal found to be isointense
(Figure 1a top-row and 1b). In addition, the area of vessel lumen (9.08 mm2)
and wall (41.31 mm2) are also provided from proposed program (Figure
1b). In Case B, decrease or no signal change of TOF and T1W was found, while
enhanced signal of T2W and the ratio of T1W+C and T1W were observed. Fibrous
tissue labeled as green color (area=21.3 mm2) was main component of
Case B. Inhomogeneous MRI signal was observed at thickened vessel wall in Case
C. Calcification (blue) and hemorrhage (pink) tissues were identified at Case C
with the areas of 8.11 mm2 and 21.09 mm2, respectively.Conclusion
Our developed process program has been proven to be capable of
semi-automatically classifying the plaque components and measuring the size of
vessel wall and lumen from multicontrast MRI. This program working with reduced operator input minimizes the possibility of random and systematic
errors and
reduces the process time in clinical diagnosis. Furthermore, it can be used as a training tool or standard for new
entrant diagnosis practice.Acknowledgements
No acknowledgement found.References
1. M. Naghavi, et al., "From vulnerable
plaque to vulnerable patient: a call for new definitions and risk assessment
strategies: Part I," Circulation, vol. 108, pp. 1664-72, Oct 7 2003.
2. J. M. Cai, et al., "Classification of
Human Carotid Atherosclerotic Lesions With In Vivo Multicontrast Magnetic Resonance
Imaging," Circulation, vol. 106, pp. 1368-1373, 2002.
3. C. Yuan, et al., "MRI of atherosclerosis in clinical
trials," NMR Biomed, vol. 19, pp. 636-54, Oct 2006.